Mitochondrial Dysfunction in Type 2 Diabetes Mellitus: Imeglimin as a Novel Therapeutic Approach. AJD [Internet]. 2025 Aug. 1 [cited 2025 Dec. 24];25(1):7-21. Available from: https://ojs.ijcp.in/index.php/AJD/article/view/1245